Division of Urology, Department of Surgery, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
J Urol. 2009 Jul;182(1):85-92; discussion 93. doi: 10.1016/j.juro.2008.11.111. Epub 2009 May 17.
We determined the associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy.
The Alberta Urology Institute Radical Cystectomy database is an ongoing multi-institutional computerized database containing data on all adult patients with a diagnosis of primary bladder cancer treated with radical cystectomy in Edmonton, Canada from April 1994 forward. The current study is an analysis of consecutive database patients treated between April 1994 and September 2007. Comorbidity information was obtained through a medical record review using the Adult Comorbidity Evaluation 27 instrument. The outcome measures were overall survival and bladder cancer specific survival. Cox proportional regression analysis was used to determine the associations between comorbidity, and overall survival and bladder cancer specific survival.
Of the database patients 160 (34%), 225 (48%) and 83 (18%) had no/mild comorbidity, moderate comorbidity and severe comorbidity, respectively. Compared to patients with no or mild comorbidity, multivariate Cox proportional regression analyses that included age, adjuvant chemotherapy, surgeon procedure volume, pathological T stage, pathological lymph node status, total number of lymph nodes removed, surgical margin status and lymphovascular invasion showed that increased comorbidity was independently associated with overall survival (moderate HR 1.59, 95% CI 1.16-2.18, p = 0.004; severe HR 1.83, 95% CI 1.22-2.72, p = 0.003) and bladder cancer specific survival (moderate HR 1.50, 95% CI 1.04-2.15, p = 0.028; severe HR 1.65, 95% CI 1.04-2.62, p = 0.034).
Increased comorbidity was independently associated with an increased risk of overall mortality and bladder cancer specific mortality after radical cystectomy.
我们确定了合并症与根治性膀胱切除术(RC)后总体生存率和膀胱癌特异性生存率之间的关联。
艾伯塔省泌尿科研究所 RC 数据库是一个正在进行的多机构计算机化数据库,包含 1994 年 4 月以来在加拿大埃德蒙顿接受 RC 治疗的原发性膀胱癌成年患者的所有数据。本研究是对 1994 年 4 月至 2007 年 9 月期间连续数据库患者的分析。通过使用成人合并症评估 27 仪器对病历进行回顾,获得合并症信息。结局测量为总生存率和膀胱癌特异性生存率。使用 Cox 比例风险回归分析来确定合并症与总生存率和膀胱癌特异性生存率之间的关联。
在数据库患者中,分别有 160 例(34%)、225 例(48%)和 83 例(18%)为无/轻度合并症、中度合并症和重度合并症。与无或轻度合并症患者相比,多变量 Cox 比例风险回归分析包括年龄、辅助化疗、外科医生手术量、病理 T 分期、病理淋巴结状态、切除的淋巴结总数、手术切缘状态和血管淋巴管侵犯,结果显示合并症增加与总体生存率(中度 HR 1.59,95%CI 1.16-2.18,p = 0.004;重度 HR 1.83,95%CI 1.22-2.72,p = 0.003)和膀胱癌特异性生存率(中度 HR 1.50,95%CI 1.04-2.15,p = 0.028;重度 HR 1.65,95%CI 1.04-2.62,p = 0.034)独立相关。
合并症增加与 RC 后总死亡率和膀胱癌特异性死亡率增加独立相关。